日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Enhanced formation of tertiary lymphoid structures shapes the anti-tumor microenvironment in gastrointestinal stromal tumors after imatinib targeted therapy

伊马替尼靶向治疗后，胃肠道间质瘤中三级淋巴结构的形成增强，从而塑造了抗肿瘤微环境。

期刊:Theranostics
影响因子:13.3
doi:10.7150/thno.123923
Tao, Ping; Wang, Jiongyuan; Fan, Peidang; Liu, Wenshuai; Lu, Weiqi; Hu, Yujie; Lu, Qun; Ma, Lijie; Tong, Hanxing; Zhang, Yong
肿瘤
肿瘤微环境
肿瘤免疫
发表日期：2026
文献求助 收藏

RNA profiling and immunohistochemistry analyses of circRNAs in imatinib-resistant gastrointestinal stromal tumors

伊马替尼耐药性胃肠道间质瘤中环状RNA的RNA谱分析和免疫组织化学分析

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-025-06598-w
Tong, Hanxing; Jia, Ning; Li, Wenyang; Xu, Jingjing; Li, Qiuyue; He, Xiaomeng; Sun, Huaqin; Corpe, Christopher; Wang, Jin
IHC
免疫/内分泌
发表日期：2025
文献求助 收藏

TRPV4 drives the progression of leiomyosarcoma by promoting ECM1 generation and co-activating the FAK/PI3K/AKT/GSK3β pathway.

TRPV4 通过促进 ECM1 生成和共同激活 FAK/PI3K/AKT/GSK3β 通路来驱动平滑肌肉瘤的进展

期刊:Cellular Oncology
影响因子:4.8
doi:10.1007/s13402-024-01008-7
Zhou Qiwen, You Yang, Zhao Yingying, Xiao Shuxiu, Song Zhengqing, Huang Chuxin, Qian Jiali, Lu Weiqi, Tong Hanxing, Zhang Yong, Wang Zhiming, Li Wei, Zhang Chenlu, Guo Xi, Luo Rongkui, Hou Yingyong, Cui Jiefeng, Lu Lili, Zhou Yuhong
信号转导
PI3K/Akt
发表日期：2025
文献求助 收藏

Editorial: Comprehensive treatment strategy for improving surgical resection rate of retroperitoneal sarcomas

社论：提高腹膜后肉瘤手术切除率的综合治疗策略

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1687933
Tong, Hanxing
发表日期：2025
文献求助 收藏

Chondroitin polymerizing factor promotes development and progression of colorectal cancer via facilitating transcription of VEGFB.

软骨素聚合因子通过促进 VEGFB 的转录来促进结直肠癌的发生和发展

期刊:Journal of Cellular and Molecular Medicine
影响因子:4.2
doi:10.1111/jcmm.18268
Huang Yuan, Zhang Zhen, Tong Hanxing, Qin Wenzheng, Li Quanlin, Ma Lili, Ren Zhong, Chen Weifeng, Zhang Yiqun, Zhong Yunshi, Yao Liqing, Zhou Pinghong
肿瘤
肠癌
肿瘤免疫
发表日期：2024
文献求助 收藏

Evaluation of AJCC staging system and proposal of a novel stage grouping system in retroperitoneal liposarcoma: the Fudan Zhongshan experience

对AJCC分期系统进行评估并提出一种新的腹膜后脂肪肉瘤分期分组系统：复旦中山医院的经验

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2024.1373762
Fan, Peidang; Tao, Ping; Wang, Zhenyu; Wang, Jiongyuan; Hou, Yingyong; Lu, Weiqi; Ma, Lijie; Zhang, Yong; Tong, Hanxing
发表日期：2024
文献求助 收藏

Development and validation of a nomogram for predicting morbidity in surgically resected primary retroperitoneal sarcoma

建立和验证用于预测手术切除的原发性腹膜后肉瘤患者并发症的列线图

期刊:BMC Surgery
影响因子:1.8
doi:10.1186/s12893-023-01941-8
Zhuang, Aobo; Chen, Yangju; Ma, Lijie; Fang, Yuan; Yang, Hua; Lu, Weiqi; Zhou, Yuhong; Zhang, Yong; Tong, Hanxing
发表日期：2023
文献求助 收藏

Does Aggressive Surgery Mean Worse Quality of Life and Functional Capacity in Retroperitoneal Sarcoma Patients?-A Retrospective Study of 161 Patients from China

积极的手术治疗是否会导致腹膜后肉瘤患者生活质量和功能能力下降？——一项来自中国的161例患者的回顾性研究

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers14205126
Zhuang, Aobo; Fang, Yuan; Ma, Lijie; Yang, Hua; Lu, Weiqi; Zhou, Yuhong; Zhang, Yong; Tong, Hanxing
发表日期：2022
文献求助 收藏

Lipidomics and Transcriptomics Differ Liposarcoma Differentiation Characteristics That Can Be Altered by Pentose Phosphate Pathway Intervention

脂质组学和转录组学揭示了可通过磷酸戊糖途径干预改变的脂肪肉瘤分化特征。

期刊:Metabolites
影响因子:3.7
doi:10.3390/metabo12121227
Song, Zhengqing; Wang, Shuaikang; Lu, Lili; Xu, Jingshen; Zhou, Qiwen; Lu, Weiqi; Tong, Hanxing; Zhang, Yong; Liu, Wenshuai; Wang, Zhiming; Li, Wei; You, Yang; Zhang, Chenlu; Guo, Xi; Luo, Rongkui; Hou, Yingyong; Wang, Chunmeng; Wang, Yuexiang; Sun, Lei; Huang, He; Zhou, Yuhong
发表日期：2022
文献求助 收藏

Prognostic Factors and Nomogram Construction for First Local Recurrent Retroperitoneal Sarcoma Following Surgical Resection: A Single Asian Cohort of 169 Cases

手术切除后首次局部复发性腹膜后肉瘤的预后因素及列线图构建：一项包含169例病例的亚洲队列研究

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2022.856754
Zhuang, Aobo; Lu, Weiqi; Fang, Yuan; Ma, Lijie; Xu, Jing; Wang, Jiongyuan; Tong, Hanxing; Zhang, Yong
发表日期：2022
文献求助 收藏